VANCOUVER, BC – Eyam Vaccines and Immunotherapeutics is pleased to publicly announce the appointment of Elizabeth Varki Jobes and Dr. Terry Pearson to the Board of Directors, and the appointment… Read More
Opportunity to accelerate your company with Takeda Canada through dedicated funding for a proof-of-concept project. The Takeda Canada Innovation Challenge opens on January 10, 2022 and will accept applications until February 6, 2022…. Read More
Expands Pfizer’s access to lipid nanoparticle (LNP) formulation technology, offering a strong strategic fit with Pfizer’s mRNA strategy Pfizer gains option to license Acuitas’ LNP technology for up to 10… Read More
ZURICH, CH – Novartis (NOVN.S)said it will license in a new drug it has been developing with Molecular Partners to treat COVID-19, the Swiss company said on Monday, after getting… Read More
AbCellera and its collaborators released new preclinical data showing the pseudovirus neutralization status of its two monoclonal antibodies, bamlanivimab and bebtelovimab (also known as LY-CoV1404), against the Omicron variant. The data confirmed… Read More
